HER receptors are important theranostic biomarkers on cervical cancer: blocking glucose metabolism enhances the therapeutic effect of HER inhibitors. uri icon

autores

  • Martinho, Olga
  • Renato Silva-Oliveira
  • Cury FP
  • Ana Martins Barbosa
  • Granja S
  • Fábio Freitas Marques
  • Miranda-Goncalves, Vera
  • Aksoy-Aksel, A.

data de publicação

  • outubro 1, 2016